SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-193474
Filing Date
2009-09-17
Accepted
2009-09-17 12:37:32
Documents
5
Period of Report
2009-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 223293
2 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 6147
3 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 6472
4 SECTION 906 CERTIFICATION OF CEO dex321.htm EX-32.1 4467
5 SECTION 906 CERTIFICATION OF CFO dex322.htm EX-32.2 4220
  Complete submission text file 0001193125-09-193474.txt   246363
Mailing Address 2530 MERIDIAN PARKWAY SUITE 3084 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 3084 DURHAM NC 27713 919-806-4414
OXYGEN BIOTHERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 002-31909 | Film No.: 091073964
SIC: 8731 Services-Commercial Physical & Biological Research